Management Team
Ignacio Asial, PhD
Co-Founder & CEO · Board
16+ years leading therapeutic antibody design and computational structural biology. 6+ years as CEO of DotBio — raised USD 10M+, closed deals worth >USD 200M. Previously Genentech, UCSF. PhD Biological Sciences, MEng, MSc.
Kelly Hew, PhD
COO
10+ years in antibody engineering project management. 6+ years as COO at DotBio managing budgeting, audits, HR, and operations. PhD Biological Sciences, PMI PMP. NTU Singapore.
Akira Liu, MB MSc
VP Corporate Development
16+ years in BD and fundraising globally from China. USD 6B+ in deals closed (GSK, BioNTech, BeOne, Avenzo). Previously DualityBio, Innovent, Sanofi. MBus, MSc Immunology.
Board of Directors
Pär Nordlund, PhD
Co-Founder · Scientific Founder · Board
30+ years in protein engineering and cancer immunology. Member of the Nobel Prize Assembly. Serial biotech entrepreneur. Karolinska Institut.
Kingsley Leung, EMBA
Board Member
15+ years leading pharma companies. Chairman, Uni-Bio Sciences; Co-Founder, Great Bay Bio. Serial biotech entrepreneur and investor.
Carl Firth, PhD EMBA
Independent Board Member
20+ years leading biotech, NASDAQ IPO. Partner at Panacea Venture. Ex-CEO ASLAN Pharmaceuticals, ex-AstraZeneca.
Haolin Sung, EMBA
Board Member
16+ years in biotech company creation and investment. Co-Founder & CEO, Protect Animal Health. Partner, Proxima Ventures; Managing Partner, Chaperone Ventures.
Beilin Le, PhD EMBA
Board Observer
10+ years as specialized healthcare investor. Managing Director at Gaorong Capital. PhD Immunology, MBA.
Scientific Advisory Board
Bertil Lindmark, MD PhD
SAB Member
30+ years in clinical oncology and immunology. Brought 10 drugs to market: Symbicort, Pulmicort, Entocort, Eklira, Duaklir and more. AstraZeneca, Almirall, Galecto.
Sujuan Ba, PhD
Strategic Advisor
CEO, National Foundation for Cancer Research (Washington DC). Co-Founder, AIM-Hi Cancer Accelerator. 30+ years as global KOL in cancer therapy.
R&D Team — Singapore
Elena OkinaPhD
Jiang ShiminPhD
Anil PillaiMSc
Henrik EngmanMSc
Abha DeshpandePhD Student (NUS)
Ng Shuan QingBSc
Ong Zi QiBEng
Syaza HaziqahBSc
Lim Zhi XianBSc
Mahirah AminResearch Associate
Partners & Shareholders
NTUitive (NTU)
Futec International
ASLAN Pharmaceuticals
Temasek Lifesciences
HKSTP
AstraZeneca
Asian Fund for Cancer Research
AIM-Hi Accelerator
Uni-Bio Science
Cstone Pharmaceuticals
Junshi / TopAlliance
Protect Animal Health
Chaperone Ventures
Proxima Ventures
Gaorong Capital
A*STAR Singapore